Dr. Lal PathLabs Limited Stock Bombay S.E.
Equities
LALPATHLAB
INE600L01024
Healthcare Facilities & Services
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,387 INR | +2.40% | +8.19% | -7.28% |
Mar. 18 | Dr Lal Pathlabs Names CEO | MT |
Mar. 17 | Dr. Lal PathLabs Limited Appoints Shankha Banerjee as Chief Executive Officer, Effective May 21, 2024 | CI |
Sales 2024 * | 22.36B 268M | Sales 2025 * | 24.94B 299M | Capitalization | 198B 2.38B |
---|---|---|---|---|---|
Net income 2024 * | 3.57B 42.84M | Net income 2025 * | 4.16B 49.92M | EV / Sales 2024 * | 8.53 x |
Net cash position 2024 * | 7.72B 92.72M | Net cash position 2025 * | 10.99B 132M | EV / Sales 2025 * | 7.51 x |
P/E ratio 2024 * |
54.5
x | P/E ratio 2025 * |
46.8
x | Employees | 4,048 |
Yield 2024 * |
0.74% | Yield 2025 * |
0.79% | Free-Float | 43.28% |
Latest transcript on Dr. Lal PathLabs Limited
1 day | +2.40% | ||
1 week | +8.19% | ||
Current month | +5.50% | ||
1 month | +5.25% | ||
3 months | -1.66% | ||
6 months | +1.62% | ||
Current year | -7.28% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 16-09-30 | |
Ved Prakash Goel
DFI | Director of Finance/CFO | - | 05-12-31 |
Arvind Lal
CHM | Chairman | 74 | 95-02-13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 58 | 23-07-26 | |
Director/Board Member | 77 | 15-08-20 | |
Arvind Lal
CHM | Chairman | 74 | 95-02-13 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 2,387 | +2.40% | 17 356 |
24-04-25 | 2,331 | 0.00% | 7,026 |
24-04-24 | 2,331 | +3.73% | 4,981 |
24-04-23 | 2,247 | -0.85% | 4,501 |
24-04-22 | 2,266 | +2.73% | 3,370 |
Delayed Quote Bombay S.E., April 26, 2024 at 06:19 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.89% | 8.36B | |
+39.49% | 3.6B | |
-32.64% | 2.73B | |
-7.71% | 2.47B | |
-15.08% | 1.77B | |
-18.29% | 1.55B | |
-40.19% | 1.22B | |
+5.57% | 1.09B | |
-15.34% | 1.03B |
- Stock Market
- Equities
- LALPATHLAB Stock
- LALPATHLAB Stock